LILLY'S HUMALOG LAUNCHED IN U.S.

Eli Lilly has launched a new premixed insulin product, Humalog Mix50/50, which the firm says gives diabetes patients improved blood sugar control after meals.

Humalog Mix50/50 (50 percent insulin lispro protamine suspension, 50 percent insulin lispro injection (rDNA origin)) is indicated for use in patients with diabetes to control high blood sugar and is available in a premixed pen delivery device, Lilly said recently.

Humalog Mix50/50 is designed to provide blood sugar control between meals but also includes a higher percentage of rapid-acting insulin for people with diabetes who need more insulin control at mealtime. The Humalog component starts lowering blood sugar more quickly than regular human insulin, allowing for convenient dosing immediately before a meal (within 15 minutes).